Todd Gleason
Analyst · H.C. Wainwright.
It's a good question again because of how we presented on the slide. Look, there's at least two ways to do a guidance EBITDA walk considering that's what we're showing you. One way is the way we didn't do it, but we could have where we break out the categories in a different way, including things like price mix, productivity. So there's an approach where you try to provide as much visibility to maybe how those impact our margins going from 10% to 15%. If I'm just using that as an example, how do you get that margin expansion by component? The other way is to, in a sense, bundle it like we did and say, look, productivity, price and mix, and the benefits of certain other, whether it's synergies or execution, is just embedded in the sales growth. So what we did was when we created the revenue walk to walk through projects that were delayed that could push over into 2025, as well as the high single-digit organic growth outside of that, as well as the M&A that we've already announced or completed, we said each of those with the components embedded in them from productivity to synergies to efficiencies will deliver, we believe, at or above 20% EBITDA margins. And the core, which was our guidance for 2024, is our core, is that the margins it's at. So the way we're walking, 2024 to 2025 from an EBITDA margin is – we're just leaving that core the same and then every component from there walks up 20%, 20% to provide you with our implied EBITDA margin outlook for 2025. Now the future is a potential opportunity for us to improve upon that. Not only the core gets better, the 2024 core that moves into 2025 with mix and productivity, but we'll see how the execution goes throughout the year. And of course, there could be some challenges, inflation, things we don't know that are going to come our way. So we're just trying to account for all that in a fairly simple even though walk.